PHS
CLVS
PFM Health Sciences’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-1,927,928
| Closed | -$56.6M | – | 125 |
|
|
2018
Q3 | $56.6M | Sell |
1,927,928
-409,297
| -18% | -$12M | 0.83% | 44 |
|
|
2018
Q2 | $106M | Buy |
+2,337,225
| New | +$106M | 1.66% | 7 |
|
|
2017
Q4 | – | Sell |
-220,487
| Closed | -$18.2M | – | 96 |
|
|
2017
Q3 | $18.2M | Sell |
220,487
-149,654
| -40% | -$12.3M | 0.36% | 66 |
|
|
2017
Q2 | $34.7M | Sell |
370,141
-636,331
| -63% | -$59.6M | 0.93% | 37 |
|
|
2017
Q1 | $64.1M | Sell |
1,006,472
-272,383
| -21% | -$17.3M | 1.6% | 21 |
|
|
2016
Q4 | $56.8M | Buy |
1,278,855
+510,765
| +66% | +$22.7M | 1.6% | 18 |
|
|
2016
Q3 | $27.7M | Sell |
768,090
-1,218,492
| -61% | -$43.9M | 0.81% | 47 |
|
|
2016
Q2 | $27.3M | Buy |
1,986,582
+112,198
| +6% | +$1.54M | 0.82% | 40 |
|
|
2016
Q1 | $36M | Sell |
1,874,384
-204,056
| -10% | -$3.92M | 1.11% | 27 |
|
|
2015
Q4 | $72.7M | Sell |
2,078,440
-474,447
| -19% | -$16.6M | 2.21% | 15 |
|
|
2015
Q3 | $235M | Sell |
2,552,887
-160,774
| -6% | -$14.8M | 6.6% | 1 |
|
|
2015
Q2 | $238M | Buy |
2,713,661
+446,905
| +20% | +$39.3M | 6.04% | 1 |
|
|
2015
Q1 | $168M | Buy |
2,266,756
+541,630
| +31% | +$40.2M | 4.64% | 1 |
|
|
2014
Q4 | $96.6M | Buy |
1,725,126
+454,917
| +36% | +$25.5M | 2.26% | 13 |
|
|
2014
Q3 | $57.6M | Buy |
1,270,209
+825,475
| +186% | +$37.4M | 1.33% | 28 |
|
|
2014
Q2 | $18.4M | Sell |
444,734
-632,086
| -59% | -$26.2M | 0.37% | 51 |
|
|
2014
Q1 | $74.6M | Sell |
1,076,820
-1,506,688
| -58% | -$104M | 1.35% | 26 |
|
|
2013
Q4 | $156M | Buy |
2,583,508
+556,600
| +27% | +$33.5M | 3.13% | 11 |
|
|
2013
Q3 | $123M | Buy |
2,026,908
+1,452
| +0.1% | +$88.3K | 2.97% | 11 |
|
|
2013
Q2 | $136M | Buy |
+2,025,456
| New | +$136M | 2.82% | 12 |
|